Axon Enterprise
AXON
$386.00
-0.98%
Axon Enterprise, Inc. is a technology company building an integrated public safety operating system, combining hardware devices like TASER energy weapons, body cameras, and drones with cloud-based software for digital evidence management and training. The company is a clear market leader and disruptor in the law enforcement technology space, leveraging its hardware-first ecosystem to create a recurring software and services revenue model. The current investor narrative is dominated by a stark disconnect between robust fundamental performance—driven by explosive demand for its AI and drone products—and a significant stock price decline, creating a debate over whether the market is mispricing its unique business model and long-term growth potential amidst short-term sentiment shifts.…
AXON
Axon Enterprise
$386.00
Related headlines
Investment Opinion: Should I buy AXON Today?
Rating & Thesis: Hold. Axon presents a high-risk, high-potential-reward scenario where compelling fundamentals are overshadowed by severe technical damage and valuation concerns, warranting a cautious stance despite analyst bullishness.
Supporting Evidence: The primary valuation metric, the forward P/E of 36.5x, prices in significant earnings growth from the current minimal base. Revenue growth of 38.5% YoY is exceptional and supports a premium, but profitability is weak (0.38% net margin). The stock trades at a P/S of 16.4x, a massive de-rating from its own historical peak, suggesting much of the valuation risk may be priced in. However, with the stock just 11.4% above its 52-week low and showing persistent negative relative strength, the technical picture argues against immediate buying.
Risks & Conditions: This Hold would upgrade to a Buy if the stock demonstrates sustained technical support above the $339 low and shows evidence of operating margin expansion in the next two quarters. It would downgrade to a Sell if revenue growth decelerates below 25% or if the stock breaks decisively below the $339 support level. Relative to its own history, the stock is fairly to undervalued after its derating, but relative to broader market earnings-based valuations, it remains expensive and reliant on flawless growth execution.
Sign up to view all
AXON 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The fundamental growth story is intact and arguably strengthening, but the technical and sentiment damage is profound and may take multiple quarters to repair. The high forward P/E leaves no room for error, making the next few earnings reports critical for margin trajectory. The stance would upgrade to bullish on a confirmed technical reversal (e.g., a sustained break above the 200-day moving average) coupled with margin expansion. It would downgrade to bearish on a breakdown below $339 or a material slowdown in top-line growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Axon Enterprise's 12-month outlook, with a consensus price target around $501.80 and implied upside of +30.0% versus the current price.
Average Target
$501.80
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$309 - $502
Analyst target range
Analyst sentiment is broadly bullish, with 10 covering firms and a clear skew towards positive ratings, as evidenced by recent actions from Morgan Stanley, Barclays, and Piper Sandler maintaining 'Overweight' or 'Buy' equivalents, while UBS maintains a 'Neutral' stance. The consensus average target price is not explicitly provided in the data, but the high level of institutional support following strong earnings suggests the implied upside from the current price of $386 is material, contingent on the market recognizing the fundamental strength highlighted in recent news. The target range is implied by the wide dispersion in estimated EPS, with a low of $5.73 and a high of $18.14, signaling significant uncertainty about the pace of future profitability expansion. The high-end targets likely assume successful execution on AI and drone demand leading to multiple expansion and accelerated growth, while the low-end may factor in potential competitive, regulatory, or execution risks. The recent pattern of reiterated bullish ratings post-earnings, without widespread downgrades, indicates analyst conviction in the long-term story remains firm despite the stock's technical breakdown.
Bulls vs Bears: AXON Investment Factors
The investment debate for Axon centers on a stark clash between exceptional fundamental growth and catastrophic technical price action. The bull case, supported by 38.5% YoY revenue growth, a de-risked valuation, and firm analyst backing, currently holds stronger evidence from an operational standpoint. However, the bear case, evidenced by a 46.7% annual decline, extreme earnings-based valuation, and persistent negative momentum, demonstrates overwhelming market skepticism. The single most important tension is whether the market's severe derating (P/S compressing from 96.6x to 16.4x) is a rational correction for a former bubble or an irrational overreaction creating a buying opportunity. The resolution hinges on Axon's ability to translate its explosive top-line growth into sustained and expanding profitability, thereby justifying its forward P/E of 36.5x.
Bullish
- Explosive Revenue Growth: Q4 2025 revenue grew 38.5% year-over-year to $796.7 million, accelerating from prior quarters and demonstrating robust demand for its integrated public safety platform. This top-line strength, particularly in the Software and Sensors segment ($305.2M), validates the company's growth narrative and recurring revenue model.
- Strong Analyst Conviction: Analyst sentiment remains bullish with 10 covering firms, including recent 'Overweight' or 'Buy' reiterations from Morgan Stanley, Barclays, and Piper Sandler following strong Q1 2026 results. The high estimated EPS target of $18.14 signals significant confidence in future profitability expansion driven by AI and drone demand.
- Valuation De-rating Creates Opportunity: The stock's current P/S ratio of 16.4x is a dramatic compression from its own historical peak of 96.6x seen in Q2 2025, indicating the market has already priced in significant skepticism. This de-rating, while the company maintains 38.5% revenue growth, creates a potential value gap if fundamentals hold.
- Solid Balance Sheet & Cash Flow: The company maintains a strong liquidity position with a current ratio of 2.53 and manageable debt (Debt/Equity of 0.59). Positive trailing twelve-month free cash flow of $75.1 million provides internal funding for growth investments without excessive leverage.
Bearish
- Severe Technical Breakdown: The stock is down 46.67% over the past year, trades just 11.4% above its 52-week low of $339.01, and has underperformed the SPY by 74.55% over the same period. This persistent negative momentum and deep oversold condition signal a profound lack of buyer conviction, potentially a value trap.
- Extreme Valuation on Earnings: The trailing P/E ratio is an astronomical 365.5x, and the forward P/E of 36.5x, while more reasonable, still prices in near-perfect execution of dramatic profit growth. Any stumble in margin expansion could trigger further multiple compression given this high embedded expectation.
- Inconsistent & Thin Profitability: Q4 2025 net income was a mere $3.0 million (net margin of 0.38%), and operating margin was 1.26%, highlighting that robust revenue growth is not translating to the bottom line. Quarterly earnings volatility (e.g., Q3 2025 net loss of -$2.2M) raises questions about near-term earnings quality.
- High Volatility & Market Sensitivity: With a beta of 1.435, the stock is approximately 44% more volatile than the broader market, amplifying downside risk during market corrections. This high volatility, combined with a short ratio of 3.11, indicates significant speculative pressure and potential for sharp declines.
AXON Technical Analysis
The stock is in a pronounced downtrend, having declined 46.67% over the past year and currently trading at $386, which is just 11.4% above its 52-week low of $339.01 and 56.4% below its 52-week high of $885.92. This positioning deep within the lower end of its annual range suggests the stock is being treated as a falling knife, reflecting severe bearish sentiment and a potential value trap, though it may also indicate an oversold condition. Recent momentum shows continued weakness, with the stock down 4.25% over the past month and 11.04% over the past three months, both periods underperforming the SPY significantly (relative strength of -9.09 and -19.19, respectively). This persistent negative momentum, despite a strong earnings report in early May, signals a deep-seated lack of buyer conviction and a divergence where positive fundamentals are failing to arrest the technical slide. Key technical levels are clear, with immediate support at the 52-week low of $339.01 and major resistance far above at the 52-week high of $885.92. A breakdown below $339 would signal a new phase of capitulation, while any sustained recovery would need to overcome significant overhead supply. The stock's beta of 1.435 confirms it is approximately 44% more volatile than the broader market, which amplifies both downside risk and potential upside during a reversal, demanding careful risk management from investors.
Beta
1.44
1.44x market volatility
Max Drawdown
-60.3%
Largest decline past year
52-Week Range
$339-$886
Price range past year
Annual Return
-46.7%
Cumulative gain past year
| Period | AXON Return | S&P 500 |
|---|---|---|
| 1m | -4.3% | +4.4% |
| 3m | -11.0% | +9.3% |
| 6m | -26.1% | +10.5% |
| 1y | -46.7% | +28.8% |
| ytd | -31.5% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXON Fundamental Analysis
Revenue growth remains exceptionally strong, with Q4 2025 revenue of $796.7 million representing a 38.5% year-over-year increase, continuing a multi-quarter trend of accelerating top-line expansion. The company's Software and Sensors segment contributed $305.2 million in the latest period, underscoring the strategic shift towards higher-margin, recurring revenue streams. This robust growth trajectory is central to the investment thesis, suggesting the core business is firing on all cylinders despite the stock's weakness. Profitability is present but inconsistent on a quarterly basis; Q4 2025 net income was a modest $3.0 million, yielding a net margin of 0.38%, though the gross margin remained healthy at 57.9%. The operating margin was a thin 1.26%, indicating that while the company can be profitable, significant investments in R&D and sales are compressing bottom-line results as it pursues growth, a common trait for a company in its expansion phase. The balance sheet is solid, with a current ratio of 2.53 and a debt-to-equity ratio of 0.59, indicating ample liquidity and a manageable debt load. Trailing twelve-month free cash flow is positive at $75.1 million, and Return on Equity (ROE) stands at 3.85%, suggesting the company is generating cash from operations to fund its growth internally, though the ROE level indicates room for improved capital efficiency as the business scales.
Quarterly Revenue
$796724000.0B
2025-12
Revenue YoY Growth
+0.38%
YoY Comparison
Gross Margin
+0.57%
Latest Quarter
Free Cash Flow
$75081000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXON Overvalued?
Given the company's positive but minimal net income, the trailing Price-to-Earnings (P/E) ratio is an extreme 365.5x, which is not meaningful; therefore, the forward P/E of 36.5x is the primary valuation metric, as it reflects the market's expectations for significant earnings growth over the next twelve months. The substantial discount from the trailing to forward multiple implies the market is pricing in a dramatic improvement in profitability, aligning with the company's raised guidance. Compared to industry averages, Axon's forward P/E of 36.5x and Price-to-Sales (P/S) ratio of 16.4x likely command a significant premium, justified by its superior growth profile (38.5% YoY revenue growth) and its unique, platform-based business model within the traditionally slower-growing Aerospace & Defense sector. Historically, the stock's current P/S ratio of 16.4x sits well below its own historical peaks seen in recent quarters (e.g., 96.6x in Q2 2025), indicating a substantial de-rating. This compression suggests the market has shifted from pricing in hyper-growth optimism to applying a more cautious multiple, potentially creating a value opportunity if the company's growth narrative remains intact, but also reflecting heightened skepticism about sustaining such high valuations.
PE
365.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -6436x~3805x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
236.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Axon's primary financial risk is its inconsistent and thin profitability amidst heavy growth investment. Q4 2025 operating margin of 1.26% and net margin of 0.38% show that the company is prioritizing growth over earnings, making its valuation highly sensitive to any deceleration in revenue growth, which is currently at 38.5% YoY. The extreme trailing P/E of 365.5x, while forward-looking, underscores that the stock is priced for flawless execution on margin expansion; a failure to deliver would trigger significant downside. Furthermore, while the balance sheet is solid, the company's Return on Equity of 3.85% indicates subpar capital efficiency for a business at its scale.
Market & Competitive Risks: The stock faces severe valuation compression risk, having already fallen 56.4% from its 52-week high. Trading at a forward P/E of 36.5x and P/S of 16.4x, it likely commands a large premium to its industrial sector peers, making it vulnerable to a broader rotation out of high-multiple growth stocks. Its high beta of 1.435 means it will likely fall more than the market in a downturn. Competitive and regulatory risks are omnipresent in the public safety tech space, as seen in recent news about privacy concerns affecting similar technologies (e.g., Amazon's Ring), which could impact Axon's drone and AI initiatives.
Worst-Case Scenario: The worst-case scenario involves a combination of execution missteps—such as a significant slowdown in revenue growth below 20% and a failure to improve operating margins—coinciding with a broader market sell-off. This could lead to a simultaneous contraction of growth multiples and earnings estimates, triggering analyst downgrades. In this adverse scenario, the stock could re-test and break below its 52-week low of $339.01, potentially falling towards the $300 level, representing a further -22% downside from the current price of $386. The historical max drawdown of -60.28% serves as a stark reminder of the stock's potential for severe losses.
FAQ
The key risks are: 1) Valuation & Execution Risk: The high forward P/E of 36.5x leaves no room for error; failure to expand margins would trigger multiple compression. 2) Technical & Sentiment Risk: The stock is in a severe downtrend (-46.7% YoY) with high short interest (ratio 3.11), indicating persistent negative momentum that can feed on itself. 3) Operational Risk: Profitability is inconsistent (Q4 net margin 0.38%), and the company must prove it can translate top-line growth to the bottom line. 4) Market Risk: With a beta of 1.435, AXON will likely fall more than the market in a downturn.
The 12-month forecast presents three scenarios. The base case (50% probability) sees the stock trading between $450 and $550 as growth continues but margin improvement is slow. The bull case (30% probability) targets $650-$750 on successful margin expansion and multiple re-rating. The bear case (20% probability) warns of a drop to $300-$339 if growth decelerates or the market sours further. The most likely outcome is the base case, where the stock remains volatile but range-bound as the company works to prove its profit potential.
AXON's valuation is a tale of two metrics. Based on sales, the P/S ratio of 16.4x represents a massive de-rating from its own historical peak (96.6x), suggesting it may be relatively undervalued if growth persists. However, based on earnings, the forward P/E of 36.5x is expensive and implies the market expects dramatic profit expansion from today's minimal base (0.38% net margin). Compared to typical industrial peers, it commands a large premium justified by its growth profile. The stock is fairly valued to slightly undervalued on a growth-adjusted basis but remains expensive on an absolute earnings basis.
AXON is a speculative buy only for investors with a high risk tolerance and a long-term horizon. The fundamental case is strong, with 38.5% revenue growth and a unique platform business, but the stock is in a severe technical downtrend, down 46.7% over the past year. The high forward P/E of 36.5x means you are paying for perfect future execution. It could be a good buy for those believing the market has overcorrected, but it requires careful risk management and a willingness to endure further volatility.
AXON is strictly a long-term investment (minimum 3-5 year horizon) and is unsuitable for short-term trading. Its high beta (1.435) and current negative momentum make it far too volatile for short-term positions. The investment thesis is based on the company executing its long-term platform strategy and growing into its valuation, which will take multiple years. There is no dividend to provide income, so the entire return is dependent on capital appreciation driven by fundamental execution over time.